SCHEDULE 14a
(RULE 14A-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934
Filed by the Registrant |X|
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
[ ] Definitive Proxy Statement
|X| Definitive Additional Materials
[ ] Soliciting Material Under Rule 14a-12
EMRISE CORPORATION
--------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
--------------------------------------------------------------------------------
(Name(s) of Person(s) Filing Proxy Statement, if Other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|X| No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
_______________________________________________________________________
(2) Aggregate number of securities to which transaction applies:
_______________________________________________________________________
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined):
_______________________________________________________________________
(4) Proposed maximum aggregate value of transaction:
_______________________________________________________________________
(5) Total fee paid:
_______________________________________________________________________
[ ] Fee paid previously with preliminary materials:
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
_______________________________________________________________________
(2) Form, Schedule or Registration Statement No.:
_______________________________________________________________________
(3) Filing Party:
_______________________________________________________________________
(4) Date Filed:
_______________________________________________________________________
2
NEWS EMRISE
CORPORATION
9485 Haven Avenue Suite 100
Rancho Cucamonga, CA 91730
(909) 987-9220 o (909) 987-5186
www.microtelinternational.com
================================================================================
FOR IMMEDIATE RELEASE
CONTACT:
Randolph D. Foote, CFO
EMRISE CORPORATION
(909) 987-9220 ext. 3201
EMRISE CORPORATION SEEKS TO INCREASE AUTHORIZED SHARES OF COMMON STOCK FROM
50,000,000 SHARES TO 150,000,000 SHARES
THE COMPANY HAS NO PRESENT INTENTION TO ISSUE THE ADDITIONAL SHARES FOR ANY
PURPOSE
RANCHO CUCAMONGA, CALIFORNIA, September 30, 2004 - EMRISE CORPORATION (OTCBB:
EMRI), a multi-national manufacturer of defense and aerospace electronic
components and subsystems and communication equipment, today announced that on
September 21, 2004, it filed a definitive proxy statement with the Securities
and Exchange Commission relating to the Company's upcoming annual meeting of
stockholders on October 19, 2004. At that meeting, the Company will be seeking
the approval of its stockholders on a number of matters, including a proposal to
increase its authorized shares of common stock from 50,000,000 to 150,000,000.
This proposal is part of number of proposed changes to the Company's Certificate
of Incorporation, many of which are designed to modernize and conform the
Company's Certificate of Incorporation to current Delaware corporate law. The
Company believes that approval of the proposed increase is in the best interests
of the Company because the increase would make additional shares of common stock
available for acquisitions or financings that could be used to enhance the
Company's business. However, the Company has no present intention to issue any
of the additional shares for these purposes. In addition, although the Company
may, in the future, be able to use the additional authorized shares of common
stock as a defensive tactic against hostile takeover attempts by issuing
additional shares under a stockholder rights plan, the Company has no present
intention to use the additional shares in such a manner.
ABOUT EMRISE CORPORATION
EMRISE CORPORATION is a multi-national manufacturer of defense and aerospace
electronic components and subsystems and communication equipment. Our electronic
components group, which includes XET Corporation and its international
subsidiaries, provides custom power conversion products, digital and rotary
switches and subsystem assemblies to the global electronic components market and
are primarily used for defense, aerospace and industrial applications. Our
communications group, consisting of CXR Corporation, Larus Corporation and CXR
Anderson Jacobson, provides network access, transmission and test equipment to
the North American, European and Asian communications industry. Founded in 1983,
EMRISE CORPORATION operates out of facilities in the United States, United
Kingdom, France and Japan. As of August 31, 2004, the Company had a total of 221
employees in our various subsidiaries and divisions.
# # #